Szemészet, 1997 (134. évfolyam, 1-4. szám)
1997-02-01 / 1. szám
14 Szemészet 134 (1997) kétségkívül részt vesznek az intraocularis miliő homeosztázisának fenntartásában, végre jobban megismerjük. Épp-úgy, mint ahogy a PG-k hatásán keresztül végre kezdjük megérteni az uveosclerális elfolyás szerepét és mechanizmusát az intraocularis nyomás szabályozásában [5, 18]. Irodalom 1 .Aim A., Camras C., Watson P: Phase 3 latanoprost studies: Masked 6-month comparisons with timolol, in the United Kingdom, Scandinavia and USA. Surv Ophthalmol (megjelenés alatt). 2. Bazan N., Allan G.: Signal transduction and gene expression in the eye: A contemporary view of the pro-inflammatory, antiinflammatory, and modulatory roles of prostaglandins and other bioactive lipids. Surv Ophthalmol (megjelenés alatt). 3. Becker В.: Does hyposecretion of aqueous humor damage the trabecular meshwork? J Glaucoma 4, 303-305 (1995). 4. Bito L Z.: Species differences in the responses of the eye to irritation and trauma: A hypothesis of divergence in ocular defense mechanism, and the choice of experimental animals for eye research. Exp Eye Res (1984) 39, 807-829. 5. Bito L Z: Physiological aspects of glaucoma and its management, in Zimmerman T., Kooner K., Sharir M. (eds): Textbook of Ocular Pharmacology. New York: Raven Press, pp. 6. Brubaker R. F: Flow of aqueous humor in humans. Invest Ophthalmol Vis Sei 32, 3145-3166 (1991). l.Drance S. M.: Glaucoma - Changing concepts. Eye 6, 337-345 (1992). 8. Greve E„ Rulo A., Hoyng F. B. J., Drance S. M.: Reduction of intraocular pressure in normal tension glaucoma with different therapeutic regimens of latanoprost: A review of short-term studies with three dose regimens. Surv Ophthalmol (megjelenés alatt). 9. Header J., Svedmyr N., Lunde H., Mandahl A.: The lack of respiratory effects of the oculo hypotensive drug latanoprost in patients with moderate asthma. Surv Ophthalmol (megjelenés alatt). 10. Imesch P. D., Wallow I. H. L, Spritz R. A., Albert D. M.: The color of the human eye: A review of morphologic correlates and some conditions that affect iridial pigmentation. Surv Ophthalmol (megjelenés alatt). 11. Lindsey J. D., Kashiwagi K., Kashiwagi F, Weinreb R. N.: Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow. Surv Ophthalmol (megjelenés alatt). 12. Mishima H. A'., Kiuchi E, Takamatsu M., Racz P, Bito L. Z.: The effects of latanoprost on diurnal and nocturnal ЮР and aqueous humor dynamics. Surv Ophthalmol (megjelenés alatt). 13. Nordlund J. J.: The pigmentary system: An expanded perspective. Ann Dermatol 6, 109-123 (1994). 14. Rácz P, Ruzsonyi M„ Nagy Z. T, Gagyi Z., Bito L. Z.: Around-theclock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol. Arch Ophthalmol 114, 268-273 (1996). 15. Resul B., Stjernschatz J., Selen G., Bito L.Z.: Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids. Surv Ophthalmol (megjelenés alatt). 16. Samuelsson В., Paolette R. et al. {eds): Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Volumes 1-23. New York, Raven Press, 1976-1995. 17. Selen G., Stjernschatz J., Resul B.: Prostaglandin-induced iridial pigmentation in primates. Surv Ophthalmol (megjelenés alatt). 18. Toris С. В., Yablonski M. E., Camras С. B. Brubaker R. F.: Mechanism of the ocular hypotensive effect of latanoprost and the maintenance of normal blood-aqueous barrier function. Surv Ophthalmol (megjelenés alatt). 19. Wistrand P, Stjernschantz J-, Ohlsson K.: The incidence and timecourse of latanoprost-induced iridial pigmentation, as a function of eye color. Surv Ophthalmol (megjelenés alatt). Cím: Dr. Bitó Z. László Department of Ophthalmology, Columbia University 630 W 168th St, New York, NY 10032 Dr. Gyorffy István 85. születésnapjára gratulálunk!
